A federal court in Indiana approved a $50 million settlement in a class action securities fraud case brought by investors against medical device company Zimmer Biomet Holdings. The investors claimed the company failed to disclose supply chain problems that led to a decrease in order fulfillment rates.
Read more
SAN FRANCISCO (CN) — A federal judge won’t let Tesla duck a lawsuit brought by investors claiming founder Elon Musk’s
Read moreA federal class action claims World Wrestling Entertainment failed to disclose that Saudi Arabia refused to pay millions of dollars for broadcast rights, and when it was revealed WWE stock fell by more than 60% in a day, closing at $40.24.
Read moreA federal class action claims directors manipulated the price of Tupperware shares beginning Jan. 30, 2019, and the price fell by 45% when its inflated figures were revealed.
Read more
SeaWorld agreed to pay $65 million to settle claims by shareholders over comments made by the park’s executives who said the documentary “Blackfish” had no effect on park attendance.
Read moreDirectors are selling Gardner Denver Holdings (industrial parts and services) too cheaply through an unfair process to Ingersoll-Rand in a proposed $5.8 billion merger, shareholders say in a federal class action.
Read moreGlen Taylor is best known in Minnesota for owning basketball teams, but he may soon be seen at a different kind of court. Stockholders in Envoy Medical Corporation say that the billionaire went for the steal to acquire their biotech firm.
Read moreA federal class action claims directors of LogMeIn breached their duty to shareholders by issuing a false and misleading proxy statement about its merger with nonparties Francisco Partners and Evergreen Coast Capital Corp., for $86.05 a share or $1.8 billion.
Read moreShareholders sued directors of Juul Labs in a superior court class action, claiming their abuse and aiding and abetting contributed to a $19 billion decline in the value of (nonparty) Altria Group, which had invested $12.8 billion in Juul.
Read moreDirectors are selling Tiffany & Co,, too cheaply through an unfair process to Moёt Hennessy-Louis Vuitton, for $135 a share or $14.5 billion, shareholders say in a federal class action.
Read moreA shareholder class action claims directors are selling the Craft Brew Alliance too cheaply through an unfair process to Anheuser-Busch, for $16.50 a share or $321 million, in King County Court.
Read moreA federal class action claims directors are selling ArQule (biopharmaceuticals) too cheaply through an unfair process to Merck Sharp & Dohme, for $20 a share or $2.7 billion.
Read moreThe Houston Municipal Employees Pension System filed a shareholder class action against Mattel, claiming its false financial statement for the third quarter of 2017 understated its net loss by more than $109 million, in federal court.
Read moreShareholders say in a federal class action that directors are selling Tech Data Corp. too cheaply through an unfair process to Apollo Global Management, for $145 per share or $5.1 billion.
Read moreA shareholder class action accusers directors of “a massive fraud that has left Akorn — a once-vibrant multibillion-dollar pharmaceutical company — in ruins,” in federal court.
Read more
Shareholders claim in a class action that Google’s $2.1 billion bid to acquire wearable fitness technology company Fitbit undervalues the company and came to fruition through an unfair process.
Read moreXL Specialty Insurance Co. claims in superior court that Starz Entertainment owes it $10 million for the $92.5 million shareholder class action settlement after Starz was purchased by Lions Gate.
Read moreShareholders claim in a federal class action that directors of The Medicines Company made false and misleading statements to support its sale to Novartis for $85 per share or $9.7 billion.
Read more